World No. 1 Aryna Sabalenka has endorsed the WTA's controversial new eligibility policy, supporting mandatory genetic testing to ensure biological fairness in women's tennis.

Key Takeaways

  • World No. 1 Aryna Sabalenka supports WTA's new eligibility policy.
  • Players must undergo a one-time genetic test for the SRY gene.
  • The goal is to ensure competitive fairness in women's tennis.
  • Testing will be conducted confidentially via blood or cheek swab.

World No. 1 Aryna Sabalenka has thrown her weight behind the Women's Tennis Association's (WTA) newly introduced eligibility policy. Speaking ahead of the 2026 Canadian Open, the Belarusian star welcomed the requirement for a one-time genetic test for players competing on the women's tour, calling it a necessary step for fairness.

Under the revised regulations, athletes will be required to undergo screening for the SRY gene, a genetic marker associated with biological sex. The WTA has emphasized that the entire process will be handled with strict confidentiality to protect the privacy of the athletes involved.

Why This Matters

BozokMedia analysis shows that this policy shift marks a significant moment in the evolution of women's professional sports. By addressing biological advantages through genetic screening, the WTA aims to safeguard the integrity of the women's category, a move that has sparked intense global debate regarding inclusivity and fairness.

"It is very important to preserve fairness on our tour. I would not find it fair for a woman to compete against a biological man." - Aryna Sabalenka

Sabalenka, arriving in Montreal as the top seed, is set to begin her campaign against Japan's Moyuka Uchijima. As the North American hard-court swing begins, Sabalenka's performance will be a crucial indicator of her form heading into the US Open later this month.

Frequently Asked Questions

1. What is the purpose of the SRY gene test?
The test aims to identify biological markers to ensure that competition remains fair and within the designated women's category.

2. How will the testing be conducted?
The WTA stated that testing will be done through either a cheek swab or a blood test, ensuring athlete privacy.

Did You Know?: The SRY gene is located on the Y chromosome and plays a critical role in male sex determination during embryonic development.